Will Bristol Myers Q4 revenues see boost from potential blockbuster Sotyktu?
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
55,827$
0,07%
Echtzeit-Aktienkurs Bristol-Myers Squibb Co.
Bid:
Ask:
Nachrichten zur Bristol-Myers Squibb Co. Aktie
Form 8-K BRISTOL MYERS SQUIBB CO For: Jan 29
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Earnings Previews: Bristol-Myers Squibb, ConocoPhillips, Merck, Sirius XM
These four companies, including one Dow Jones industrial, are set to report quarterly earnings early Thursday....…
How Will Bristol Myers Squibb Stock Trend Post Q4 Results?
A decline in Revlimid sales will likely more than offset sales growth for Eliquis, Opdivo, and Reblozyl....…
Bristol Myers Squibb (BMY) Stock Sinks As Market Gains: What You Should Know
Bristol Myers Squibb (BMY) closed at $72.45 in the latest trading session, marking a -0.74% move from the prior day....…
Bristol Myers Gets CHMP Backing for Sotyktu, Reblozyl >BMY
Bristol Myers Gets CHMP Backing for Sotyktu, Reblozyl >BMY...…
Bristol Myers wins EU backing to expand label for anemia therapy
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Intravitreal Injectables Global Market Report 2022: Featuring Allergan, Bristol-Myers Squibb, Novartis, F.Hoffman-La Roche & More
DUBLIN, Jan. 26, 2023 /PRNewswire/ -- The "Intravitreal Injectables Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key…
iVexSol closes $23.8M series A-3 financing by Bristol Myers Squibb, Charles River, Asahi Kasei
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Earnings Preview: Bristol Myers Squibb (BMY) Q4 Earnings Expected to Decline
Bristol Myers (BMY) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its…
OstoBuddy and South Asian IBD Alliance Named Winners of Innovation Challenge, in Collaboration with Bristol Myers Squibb, to Address Unmet Needs in Inflammatory Bowel Disease
PRINCETON, N.J., Jan. 26, 2023 /PRNewswire/ -- Lyfebulb, a patient-empowerment platform that bridges patients with industry to support user-driven innovation,…
Bristol-Myers earns bullish views at Cantor on breakout potential
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Bristol Myers Squibb Wins Another Approval for Its Multimillion-Dollar Cancer Drug
A cutting-edge cancer treatment from the drugmaker was recently approved in Japan to treat a type of lymphoma....…
The Zacks Analyst Blog Highlights Bristol-Myers Squibb, Honeywell, Sony, Airbnb and Republic Services
Bristol-Myers Squibb, Honeywell, Sony, Airbnb and Republic Services are included in this Analyst Blog....…
Form 8-K BRISTOL MYERS SQUIBB CO For: Jan 09
Um den gesamten Artikel unter streetinsider.com zu lesen, klicken Sie bitte auf die Überschrift...…
Outlook on the Nasopharyngeal Cancer Global Market to 2028 - Featuring Biocon, Bristol-Myers Squibb, Cyclacel Pharmaceuticals and Eli Lilly and Co Among Others
DUBLIN, Jan. 9, 2023 /PRNewswire/ -- The "Global Nasopharyngeal Cancer Market Research and Forecast, 2022-2028" report has been added to…
Schrödinger inks drug discovery licensing deals with Bristol Myers, Otsuka
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...…
Dragonfly Therapeutics gibt das sechste Dragonfly TriNKET Opt-in von Bristol Myers Squibb bekannt
Dragonfly Therapeutics, Inc.: Waltham, Massachusetts (ots/PRNewswire) - Seit ihrer ursprünglichen Zusammenarbeit im Jahr 2017, die sich auf hämatologische Malignitäten konzentrierte,…
Dragonfly Therapeutics gibt das sechste Dragonfly TriNKET Opt-in von Bristol Myers Squibb bekannt
Seit ihrer ursprünglichen Zusammenarbeit im Jahr 2017, die sich auf hämatologische Malignitäten konzentrierte, haben die Unternehmen zwei zusätzliche Kooperationen vereinbart,…
Is Trending Stock Bristol Myers Squibb Company (BMY) a Buy Now?
Bristol Myers (BMY) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring…
Dragonfly Therapeutics Announces Sixth Dragonfly TriNKET Opt-in by Bristol Myers Squibb
Since their original 2017 collaboration focusing on hematology malignancies, the companies have agreed to two additional collaborations which include oncology…
Active Pharmaceutical Ingredient Global Market Report 2023: Featuring Teva Pharmaceutical, Bristol-Myers Squibb, Merck
DUBLIN, Jan. 4, 2023 /PRNewswire/ -- The "Active Pharmaceutical Ingredient Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028:…
XETR : DIVIDEND/INTEREST INFORMATION - 05.01.2023 - US1101221083
Das Instrument BRM US1101221083 BRISTOL-MYERS SQUIBBDL-10 EQUITY wird cum Dividende/Zinsen gehandelt am 04.01.2023 und ex Dividende/Zinsen am 05.01.2023
The instrument BRM…
Will Bristol Myers (BMY) Beat Estimates Again in Its Next Earnings Report?
Bristol Myers (BMY) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients…
Copy_Lotte Biologics completes acqusition of BMS drug plant
Lotte Group has completed a $160 million acquisition of US drug firm Bristol Myers Squibb, the group’s drug manufacturing unit…